De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation
β Scribed by Fred Poordad; Robert Gish; Adil Wakil; Richard Garcia-Kennedy; Paul Martin; Francis Y. Yao
- Book ID
- 114440712
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 68 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Alcohol abuse is the most common cause of end-stage liver disease in the United States, but many transplant centers are unwilling to accept alcoholic patients because of their supposed potential for recidivism, poor compliance with the required immunosuppression regimen and resulting failure of the
Hepatic steatosis is a recognized problem in patients after orthotopic liver transplant (OLT). However, de novo development of nonalcoholic fatty liver disease (NAFLD) has not been well described. The aim of this study was to determine the prevalence and predictors of de novo NAFLD after OLT. A retr
Achieving long-term graft survival and mortality is the primary goal of liver transplantation (LT). However, disease recurrence remains a stumbling block, especially among patients with hepatitis C. In such patients, worse outcomes may be associated with comorbidities (i.e., hyperlipidemia, hyperten